IgG-4 Levels in Systemic Sclerosis

N/ACompletedNCT04219592

Meir Medical Center154 enrolled

Overview

This is an observational - non interventional study. The investigators will compare IgG4 levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients from Meir Medical Center.

IgG4 levels will be obtained from medical records of 80 SSc patients between the years 2000-2019. These will be compared to IgG4 levels from sera of 80 healthy donors (from Israel blood-bank - MDA). Correlations between IgG4 levels and the following will be made: age, sex, disease type (limited or diffused SSc), disease duration, medications.

Study Type

OBSERVATIONAL

Enrollment

154

Conditions

Systemic Sclerosis

Interventions

IgG4 measurement (non-interventional, just obtaining data from medical records)DIAGNOSTIC_TEST

IgG4 measurement in mg/dL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * SSc patients Exclusion Criteria: * other chronic co-morbidities

Locations (1)

Meir Medical Center

Kfar Saba, Israel

Outcomes

Primary Outcomes

IgG4 measurement

quantifying IgG4 in each group and in SSc subgroups based on disease type, organs involved, medications.

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.